Enlitic
Sergio Duchini is a highly accomplished leader in the biotechnology and finance sectors, currently serving as Chair of Neurizon Therapeutics, where efforts focus on developing innovative therapies for neurodegenerative diseases. Duchini also holds positions as Non-Executive Director at QBiotics Group Limited and Enlitic, contributing strategic governance and financial oversight. Additionally, memberships on advisory councils and committees, including Medicines Australia and Industry Innovation and Science Australia, highlight a commitment to advancing healthcare and innovation. Past leadership roles include Chairman of Lymphoma Australia, Non-Executive Director at AusBiotech, and a distinguished career at Deloitte, where significant contributions were made in tax services and corporate governance. Educational qualifications include degrees from the University of Melbourne and Harvard Business School, alongside professional designations as a Chartered Accountant and Chartered Tax Adviser.
This person is not in any teams
This person is not in any offices
Enlitic
1 followers
Enlitic is shaping the next generation of intelligent healthcare tools to help patients around the globe. By using AI and deep learning, they help health systems address high value challenges at every stage of the clinical workflow. They believe they are working on one of the biggest social impact opportunities in healthcare and are deploying our technology around the globe. They will not stop developing clinically relevant solutions designed to support our healthcare partners in eliminating the barriers to better patient care and outcomes.